Plasma Proteins - Webinars

Learn about the clinical and laboratory aspects impacting serum free light chains testing in diagnosis and monitoring of monoclonal gammopathies.

Understand the concept of excluding intrathecal inflammation by measuring kappa free light chain (kFLC) in CSF and serum and hear the results of a prospective multicenter validation study of this new laboratory workflow that integrates the free light chains kappa quotient in CSF analysis.

Learn about the significance of monoclonal gammopathy of renal significance (MGRS), including diagnosis and management of the disease.

Learn about IgG4-related disease, including how the disease is diagnosed and managed in clinics and laboratories.

Learn about Serum amyloid A (SAA) and its utility in COVID-19 disease management.

Learn more about kidney dysfunction diagnosis, including recent recommendations on the calculation of estimated glomerular filtration rate (eGFR).

Learn about free light chain (FLC) testing in multiple myeloma and the influence of kidney function on FLC test results.

Learn about FLC testing in multiple myeloma and the influence of kidney function on FLC test results.

Learn about free light chain (FLC) testing in the detection and monitoring of amyloidosis.

Understand the key role of free light chain (FLC) testing in the detection and monitoring of MGUS.

Learn about the role of the kappa free light chain index in cerebrospinal fluid for diagnosis and management of multiple sclerosis.

Learn about the value of serum amyloid A (SAA) and other inflammation markers in the management of hospitalized COVID-19 patients.

Understand the use of and importance of monitoring anti-TNF-α drugs in patients suffering from rheumatic diseases.

The performance and benefits of Free Light Chain assays and how to easily implement into routine laboratory testing.

Learn about the clinical and laboratory investigation of multiple myeloma and MGUS, and the potential clinical usage of the N Latex FLC assay in evaluation of MGUS.